Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.
Explore the top headlines of the week including innovation in scalp treatment, therapeutic updates in rosacea, and acne vulgaris insights from James Del Rosso, DO.
This randomized clinical trial assesses the efficacy and adverse events of baricitinib combined with narrowband UV-B in adults with severe, active, nonsegmental vitiligo.
In case you missed it, this week we had news about awareness resources from the Skin Cancer Foundation, burn care disparities in skin of color,…
Although novel artificial intelligence-powered diagnostic applications are readily available to the public, how much can clinicians trust these tools?
The meta-analysis found that HA fillers enhance skin hydration and glow, but do not significantly impact elasticity.
85% of Chinese PN patients saw a PP-NRS improvement of ≥ 4 points after 12 weeks of treatment.
JCAD October 2024 Issue Highlights Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in…
This nonrandomized clinical trial evaluates the long-term safety and efficacy of continuous treatment with deucravacitinib through 3 years in the POETYK PSO-1, PSO-2, and long-term…
Younger researchers are taking on the challenges of peer review — and reaping some unexpected benefits
